15 results

1 Genomic technologies for detecting structural variations in hematologic malignancies
Mi-Ae Jang
KMSID: 1516086299   Blood Res. 2024;59:1.  Published online 2024 February 13    DOI: http://dx.doi.org/10.1007/s44313-024-00001-1
      
2 Adding MYC/BCL2 double expression to NCCN‑IPI may not improve prognostic value to an acceptable level
Naree Warnnissorn, Nonglak Kanitsap, Pimjai Niparuck, Paisarn Boonsakan, Prapasri Kulalert, Wasithep Limvorapitak, Lantarima Bhoopat, Supawee Saengboon, Chinnawut Suriyonplengsaeng, Pichika Chantrathammachart, Teeraya Puavilai, Suporn Chuncharunee
KMSID: 1516086298   Blood Res. 2024;59:2.  Published online 2024 February 19    DOI: http://dx.doi.org/10.1007/s44313-024-00006-w
      
3 Real‑world incidence and risk factors of bortezomib‑related cardiovascular adverse events in patients with multiple myeloma
Bitna Jang, Jonghyun Jeong, Kyu-Nam Heo, Youngil Koh, Ju-Yeun Lee
KMSID: 1516086297   Blood Res. 2024;59:3.  Published online 2024 February 19    DOI: http://dx.doi.org/10.1007/s44313-024-00004-y
      
4 Upregulation of lnc‑FOXD2‑AS1, CDC45, and CDK1 in patients with primary non‑M3 AML is associated with a worse prognosis
Saba Manoochehrabadi, Morteza Talebi, Hossein Pashaiefar, Soudeh Ghafouri-Fard, Mohammad Vaezi, Mir Davood Omrani, Mohammad Ahmadvand
KMSID: 1516086301   Blood Res. 2024;59:4.  Published online 2024 February 19    DOI: http://dx.doi.org/10.1007/s44313-024-00002-0
      
5 Peripheral T‑cell lymphoma, NOS in bone marrow and heart
Hye Won Lee, Ja Young Lee
KMSID: 1516086296   Blood Res. 2024;59:5.  Published online 2024 February 26    DOI: http://dx.doi.org/10.1007/s44313-024-00009-7
      
6 Comparable outcomes with low‑dose and standard‑dose horse anti‑thymocyte globulin in the treatment of severe aplastic anemia
Arihant Jain, Aditya Jandial, Thenmozhi Mani, Kamal Kishore, Charanpreet Singh, Deepesh Lad, Gaurav Prakash, Alka Khadwal, Reena Das, Neelam Varma, Subhash Varma, Pankaj Malhotra
KMSID: 1516086300   Blood Res. 2024;59:6.  Published online 2024 February 26    DOI: http://dx.doi.org/10.1007/s44313-024-00003-z
      
7 Gaucher or pseudo‑Gaucher cells
Gurpreet Kaur, Ankur Ahuja, Ganesh Kumar Vishwananthan, Arijit Sen
KMSID: 1516086341   Blood Res. 2024;59:7.  Published online 2024 February 28    DOI: http://dx.doi.org/10.1007/s44313-024-00005-x
      
8 Cytotoxic T lymphocyte‐associated antigen‐4 (CTLA‑4) gene polymorphisms in a cohort of Egyptian patients with immune thrombocytopenia (ITP)
Doaa Mohamed El Demerdash, Maha Mohamed Saber, Alia Ayad, Kareeman Gomaa, Mohamed Abdelkader Morad
KMSID: 1516086339   Blood Res. 2024;59:8.  Published online 2024 March 1    DOI: http://dx.doi.org/10.1007/s44313-024-00011-z
      
9 Impact of CYP1A1 variants on the risk of acute lymphoblastic leukemia: evidence from an updated meta‑analysis
Imen Frikha, Rim Frikha, Moez Medhaffer, Hanen Charfi, Fatma Turki, Moez Elloumi
KMSID: 1516086344   Blood Res. 2024;59:9.  Published online 2024 March 4    DOI: http://dx.doi.org/10.1007/s44313-024-00007-9
      
10 Acute erythroid leukemia leading to the diagnosis of Schwachman‑Diamond syndrome
Bernhard Strasser, Sebastian Mustafa, Josef Tomasits, Alexander Haushofer
KMSID: 1516086342   Blood Res. 2024;59:10.  Published online 2024 March 6    DOI: http://dx.doi.org/10.1007/s44313-024-00008-8
      
11 The role of next‑generation sequencing in hematologic malignancies
Young‑Uk Cho
KMSID: 1516086343   Blood Res. 2024;59:11.  Published online 2024 March 6    DOI: http://dx.doi.org/10.1007/s44313-024-00010-0
      
12 Genomic testing for germline predisposition to hematologic malignancies
Sang Mee Hwang
KMSID: 1516086340   Blood Res. 2024;59:12.  Published online 2024 March 8    DOI: http://dx.doi.org/10.1007/s44313-024-00012-y
      
13 Rare pseudo‑chediak‑higashi inclusions in a patient with disseminated diffuse large B cell lymphoma
Can Yan, Zenghui Fang, Jinlin Liu
KMSID: 1516086775   Blood Res. 2024;59:13.  Published online 2024 March 25    DOI: http://dx.doi.org/10.1007/s44313-024-00013-x
      
14 Transfusion‑transmitted infections
Han Joo Kim, Dae‑Hyun Ko
KMSID: 1516086840   Blood Res. 2024;59:14.  Published online 2024 April 12    DOI: http://dx.doi.org/10.1007/s44313-024-00014-w
      
15 What is new in acute myeloid leukemia classification?
Hee Sue Park
KMSID: 1516086841   Blood Res. 2024;59:15.  Published online 2024 April 12    DOI: http://dx.doi.org/10.1007/s44313-024-00016-8
      
Articles from Blood Research are provided here courtesy of Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of